XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Statement of Cash Flows [Abstract]    
Interest Paid, Excluding Capitalized Interest, Operating Activities $ 2,111 $ 4,214
OPERATING ACTIVITIES    
Net income 5,398 3,064
Undistributed Earnings Of Equity Method And Other Investments 0 (94)
Reconciliation of net income to net cash provided by operating activities:    
Provision for loan losses (523) 788
Depreciation 612 668
Amortization of OMSR 177 97
Amortization of acquisition intangibles 7 13
Net amortization of AFS securities 438 444
Debt Securities, Available-for-sale, Realized Gain (Loss) 0 (71)
Net gain on sale of mortgage loans (745) (151)
Mortgage Servicing Rights (MSR) Impairment (Recovery) 0 245
Bank Owned Life Insurance Income, Net of Expense 177 170
Other Real Estate, Foreclosed Assets, and Repossessed Assets, Valuation Adjustments (28) 42
Bank Owned Life Insurance Income, From Policy Redemption (146) (524)
Proceeds from loan sales (17,692) (8,890)
Proceeds from loan sales 19,213 8,717
Net changes in operating assets and liabilities which provided (used) cash:    
Accrued interest receivable 460 (521)
Other assets 997 (379)
Accrued interest payable and other liabilities (1,135) (111)
Net cash provided by (used in) operating activities 7,076 3,394
Activity in AFS securities    
Proceeds from Sale of Debt Securities, Available-for-sale 0 26,855
Maturities and calls 19,388 12,674
Purchases (51,467) (11,012)
Net loan principal (originations) collections 42,365 10,487
Proceeds from sales of foreclosed assets 193 51
Purchases of premises and equipment (358) (372)
Proceeds from Life Insurance Policy 558 1,458
Payments to Acquire Other Investments (226) (150)
Net cash provided by (used in) investing activities 10,453 39,991
FINANCING ACTIVITIES    
Net increase (decrease) in deposits 77,264 8,232
Increase in other borrowed funds (16,780) (12,828)
Cash dividends paid on common stock (2,130) (2,122)
Proceeds from issuance of common stock 387 1,330
Common stock repurchased (1,149) (1,168)
Common stock purchased for deferred compensation obligations (194) (650)
Increase (decrease) in cash and cash equivalents 74,927 36,179
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 321,567 96,751
Cash and cash equivalents at beginning of period 246,640  
Cash and cash equivalents at end of period 321,567  
Net cash provided by (used in) financing activities 57,398 (7,206)
SUPPLEMENTAL NONCASH INFORMATION:    
Transfers of loans to foreclosed assets $ 78 $ 117